The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications are expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.
The system/accelerators segment is expected to account for the largest market share during the forecast period.
Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & after loaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.
The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period.
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.
Europe to account for the second-largest share of the global market in 2019.
The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Europe is expected to account for the second-largest share of the global intraoperative radiation therapy market in 2019. The growing incidence of cancer, supportive government initiatives, and the implementation of intraoperative radiation therapy market training programs & conferences/symposiums are the major factors propelling the demand for intraoperative radiation therapy market products in Europe. Furthermore, several key market players are focusing on enhancing their intraoperative radiation therapy market products to improve the quality of patient care across Europe.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights 4.1 Intraoperative Radiation Therapy Market Overview 4.2 Intraoperative Radiation Therapy Market, by Product & Service, 2020 Vs. 2025 (USD Million) 4.3 North America: Intraoperative Radiation Therapy Products Market, by Type, 2020 Vs. 2025 (USD Million) 4.4 Asia-Pacific: Intraoperative Radiation Therapy Market, by Technology, 2020 Vs. 2025 (USD Million) 4.5 Europe: Intraoperative Radiation Therapy Market, by Application & Country (2019) 4.6 Intraoperative Radiation Therapy Market: Geographic Growth Opportunities
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 184.108.40.206 Growing Global Prevalence of Cancer 220.127.116.11 Improving Reimbursement Scenario 18.104.22.168 Procedural Advantages Over Ebrt 22.214.171.124 Technological Advancements 5.2.2 Restraints 126.96.36.199 Dearth of Trained Personnel 188.8.131.52 Strong Market Positioning of Alternative Therapies 5.2.3 Opportunities 184.108.40.206 Emerging Economies Offer High Growth Potential 220.127.116.11 Growing Applications of IORT 5.2.4 Challenges 18.104.22.168 Risk of Radiation Exposure 5.3 Impact of COVID-19 on the Intraoperative Radiation Therapy Market 5.4 Global Regulatory Scenario 5.4.1 North America 22.214.171.124 US 126.96.36.199 Canada 5.4.2 Europe 5.4.3 Asia-Pacific 188.8.131.52 Japan 184.108.40.206 China 220.127.116.11 India 5.5 Value Chain Analysis: Global Intraoperative Radiation Therapy Market 5.6 Ecosystem Coverage: Global Radiotherapy Market
6 Intraoperative Radiation Therapy Market, by Product & Service 6.1 Introduction 6.2 IORT Products 6.2.1 Intraoperative Radiation Therapy Products Market, by Technology 6.2.2 Intraoperative Radiation Therapy Products Market, by Application 6.2.3 Systems & Accelerators 18.104.22.168 Affordability of Systems & Accelerators is Supporting Their Adoption 22.214.171.124 Intraoperative Radiation Therapy Market for Systems & Accelerators, by Technology 126.96.36.199 Intraoperative Radiation Therapy Market for Systems & Accelerators, by Application 6.2.4 Applicators & Afterloaders 188.8.131.52 Growing Approvals of Applicators & Afterloaders for the Treatment of Different Cancer Types is Supporting the Growth of this Segment 184.108.40.206 Intraoperative Radiation Therapy Market for Applicators & Afterloaders, by Technology 220.127.116.11 Intraoperative Radiation Therapy Market for Applicators & Afterloaders, by Application 6.2.5 Treatment Planning Systems 18.104.22.168 Technological Advancements & Growing Regulatory Approvals are Supporting Market Growth 22.214.171.124 Intraoperative Radiation Therapy Market for Treatment Planning Systems, by Technology 126.96.36.199 Intraoperative Radiation Therapy Market for Treatment Planning Systems, by Application 6.2.6 Accessories 188.8.131.52 Growing Number of IORT Procedures to Drive the Adoption of IORT Accessories 184.108.40.206 Intraoperative Radiation Therapy Market for Accessories, by Technology 220.127.116.11 Intraoperative Radiation Therapy Market for Accessories, by Application 6.3 IORT Services 6.3.1 Need for Frequent Software Upgrades to Drive Market Growth 6.3.2 Intraoperative Radiation Therapy Market for Services, by Technology 6.3.3 Intraoperative Radiation Therapy Market for Services, by Application
7 Intraoperative Radiation Therapy Market, by Technology 7.1 Introduction 7.2 Electron IORT 7.2.1 Minimal Treatment Time of this Procedure Has Increased Its Adoption in the Market 7.3 Intraoperative Brachytherapy 7.3.1 Lower Cost Than Ioert & Better Dosimetric Distribution are the Key Factors Supporting Market Growth 8 Intraoperative Radiation Therapy Market, by Application 8.1 Introduction 8.2 Breast Cancer 8.2.1 Growing Number of Breast Cancer Cases Across the Globe is Fueling the Adoption of IORT 8.3 Brain Tumor 8.3.1 Growing Number of Brain Tumor Cases to Drive Market Growth 8.4 Gastrointestinal Cancer 8.4.1 IORT Offers a Suitable Alternative for Gastrointestinal Cancer Treatment as Opposed to Surgery or Conventional Radiation 8.5 Head & Neck Cancer 8.5.1 IORT is Highly Efficient in the Treatment of Head & Neck Cancer as It Offers Better Tumor Control 8.6 Colorectal Cancer 8.6.1 IORT is Proven Effective for Advanced Local and Recurrent Colorectal Cancer Treatment in Combination with Preoperative Ebrt 8.7 Endometrial & Cervical Cancer 8.7.1 IORT in Combination with Radical Resection Procedures is a Curative Option for Patients with Recurrent Endometrial Cancer 8.8 Lung Cancer 8.8.1 Alternative Treatment Options for Lung Cancer is Expected to Hamper the Growth of this Segment 8.9 Other Cancers 9 Intraoperative Radiation Therapy Market, by Region 9.1 Introduction 9.2 North America 9.3 Europe 9.4 Asia-Pacific 9.5 Latin America 9.6 Middle East & Africa 10 Competitive Landscape 10.1 Overview 10.2 Market Share Analysis 10.3 Key Market Developments 10.3.1 Product Launches & Approvals 10.3.2 Acquisitions 10.3.3 Partnerships, Collaborations, and Agreements 10.3.4 Expansions
11 Company Evolution Matrix and Company Profiles 11.1 Competitive Evaluation Matrix and Methodology 11.1.1 Competitive Leadership Mapping: Major Market Players (2019) 11.1.2 Stars 11.1.3 Emerging Leaders 11.1.4 Emerging Companies 11.1.5 Pervasive 11.2 Company Profiles 11.2.1 Zeiss Group 11.2.2 Icad, Inc. 11.2.3 Eckert & Ziegler 11.2.4 Ariane Medical Systems Ltd. 11.2.5 Becton, Dickinson and Company 11.2.6 Elekta Ab 11.2.7 Gmv Innovating Solutions 11.2.8 Intraop Medical, Inc. 11.2.9 Isoaid, LLC 11.2.10 Isoray, Inc. 11.2.11 Panacea Medical Technologies Pvt. Ltd. 11.2.12 Seedos Ltd. 11.2.13 Sensus Healthcare, Inc. 11.2.14 S.I.T. Sordina IORT Technologies S.P.A. 11.2.15 Varian Medical Systems, Inc. 11.2.16 Other Companies 18.104.22.168 Salutaris Medical Devices 22.214.171.124 Brainlab Ag 126.96.36.199 Raysearch Laboratories 188.8.131.52 Remedi Co., Ltd. 184.108.40.206 Merit Medical Systems 12 Appendix 12.1 Discussion Guide 12.2 Knowledge Store: The Subscription Portal 12.3 Available Customizations